BackCatheter Precision Overview

Catheter Precision Other Current Liabilities

Latest other current liabilities for RMED: $4.5M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$4.48M
101.30% YoYΔ $2.25M vs prior year quarter

Peer trimmed avg / median

Loading

Catheter Precision Other Current Liabilities History

Loading

Catheter Precision vs. peers: Other Current Liabilities Comparison

Loading

Catheter Precision Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Catheter Precision (RMED) FAQ

The latest other current liabilities for RMED is $4.5M as of June 2026. That compares with $2.2M in the prior-year period — up 101.3% year over year. Investors often review this figure alongside Catheter Precision's historical trend and sector peers before judging valuation or financial health.

Over the past year, RMED's other current liabilities moved from $2.2M to $4.5M — a 101.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Catheter Precision's operating scale or balance-sheet position.

A other current liabilities figure of $4.5M for RMED is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RMED's other current liabilities ($4.5M), review year-over-year change from $2.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Catheter Precision's other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.